Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Mixed V419 and Pediacel Schedule in Infants
NCT01839188Phase 3Completed
- Sponsor
- MCM Vaccine
- Start
- May 2013
- Primary completion
- Mar 2014
- Modality
- Split/Subunit Vaccines
01
Overview
A Phase 3 trial of DTaP-IPV-Hep B-PRP-T vaccine in diphtheria, Tetanus, pertussis, hepatitis B (HBV), poliomyelitis, sponsored by MCM Vaccine. Started May 2013; status: completed.
02
Drugs
DTaP-IPV-Hep B-PRP-T vaccine
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on NCT01839188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01839188.